NOVABAY PHARMACEUTICALS INC's ticker is NBY and the CUSIP is 66987P201. A total of 16 filers reported holding NOVABAY PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $21,000 | -55.3% | 195,576 | +3.4% | 0.00% | – |
Q2 2022 | $47,000 | +9.3% | 189,124 | +28.4% | 0.00% | – |
Q1 2022 | $43,000 | -21.8% | 147,318 | 0.0% | 0.00% | – |
Q4 2021 | $55,000 | -41.5% | 147,318 | 0.0% | 0.00% | – |
Q3 2021 | $94,000 | -4.1% | 147,318 | 0.0% | 0.00% | – |
Q2 2021 | $98,000 | -26.9% | 147,318 | 0.0% | 0.00% | – |
Q1 2021 | $134,000 | +173.5% | 147,318 | +109.1% | 0.00% | – |
Q4 2020 | $49,000 | -3.9% | 70,444 | 0.0% | 0.00% | – |
Q3 2020 | $51,000 | -37.0% | 70,444 | 0.0% | 0.00% | – |
Q2 2020 | $81,000 | +1250.0% | 70,444 | +579.2% | 0.00% | – |
Q1 2020 | $6,000 | -50.0% | 10,371 | -50.0% | 0.00% | – |
Q4 2019 | $12,000 | +100.0% | 20,742 | +100.0% | 0.00% | – |
Q3 2019 | $6,000 | -64.7% | 10,371 | 0.0% | 0.00% | – |
Q2 2019 | $17,000 | – | 10,371 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Virtu Financial LLC | 46,903 | $34,000 | 0.01% |
TOWNSQUARE CAPITAL LLC | 53,672 | $40,000 | 0.00% |
NVWM, LLC | 2,997 | $2,000 | 0.00% |
VANGUARD GROUP INC | 152,309 | $111,000 | 0.00% |
UBS Group AG | 2,000 | $1,000 | 0.00% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 25,000 | $18,000 | 0.00% |
Sugarloaf Wealth Management, LLC | 2,000 | $1,000 | 0.00% |
OSAIC HOLDINGS, INC. | 5,260 | $4,000 | 0.00% |
BANK OF AMERICA CORP /DE/ | 3,000 | $2,000 | 0.00% |
WELLS FARGO & COMPANY/MN | 7,514 | $5,000 | 0.00% |